ETFs With Most Upside to Analyst Targets: VTI, OnKure Therapeutics, FAT Brands, Metagenomi
ByAinvest
Wednesday, Sep 24, 2025 9:14 am ET1min read
FAT--
OnKure Therapeutics Inc (OKUR) is expected to experience a 1074.17% increase, while FAT Brands Inc (FAT) and Metagenomi Inc (MGX) are projected to rise by 441.28% and 441.28% respectively [1]. These projections indicate strong analyst confidence in the future performance of these companies, which are key components of the VTI portfolio.
Analysts have highlighted the potential for substantial gains in these stocks, which could significantly boost the overall performance of the VTI. However, it is essential to note that the implied target price and projected gains are subject to market volatility and various risk factors.
For investors and financial professionals, these insights provide valuable information to consider when evaluating the VTI and its underlying holdings. As always, it is crucial to conduct thorough research and consult with a financial advisor before making investment decisions.
References
[1] https://www.benzinga.com/crypto/cryptocurrency/25/09/47815828/dogecoin-down-9-in-1-week-but-etf-preparations-fuel-bulls-hopes
MGX--
OKUR--
DOGE--
The Vanguard Total Stock Market ETF (VTI) has an implied analyst target price of $360.25 per unit, which represents a 9.80% upside from its recent trading price of $328.09. Analysts see significant potential gains for three of VTI's underlying holdings: OnKure Therapeutics Inc (OKUR), FAT Brands Inc (FAT), and Metagenomi Inc (MGX), with upside ranging from 1074.17% to 441.28%.
The Vanguard Total Stock Market ETF (VTI) has captured the attention of financial analysts with an implied target price of $360.25 per unit, representing a 9.80% upside from its recent trading price of $328.09 [1]. This optimism is driven by significant potential gains for three of VTI's underlying holdings: OnKure Therapeutics Inc (OKUR), FAT Brands Inc (FAT), and Metagenomi Inc (MGX).OnKure Therapeutics Inc (OKUR) is expected to experience a 1074.17% increase, while FAT Brands Inc (FAT) and Metagenomi Inc (MGX) are projected to rise by 441.28% and 441.28% respectively [1]. These projections indicate strong analyst confidence in the future performance of these companies, which are key components of the VTI portfolio.
Analysts have highlighted the potential for substantial gains in these stocks, which could significantly boost the overall performance of the VTI. However, it is essential to note that the implied target price and projected gains are subject to market volatility and various risk factors.
For investors and financial professionals, these insights provide valuable information to consider when evaluating the VTI and its underlying holdings. As always, it is crucial to conduct thorough research and consult with a financial advisor before making investment decisions.
References
[1] https://www.benzinga.com/crypto/cryptocurrency/25/09/47815828/dogecoin-down-9-in-1-week-but-etf-preparations-fuel-bulls-hopes

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet